Senior Manager, Product Quality Integrator — Flexible Hours

8170-Janssen Pharmaceutical Sciences Unlimited Company Legal Entity; Wallingstown; On-site; EUR 120,000 - 160,000; Full time

Benefits offered by this job

Annual bonus

Vacation days

Parental leave

Bereavement leave

Caregiver leave

Well-being reimbursement

Insurance plans

Job summary

Johnson & Johnson Innovative Medicine (J&J IM) is recruiting a Senior Manager, Product Quality Integrator, Quality Asset Management Biotherapeutics. The position will be based at our European sites.

The Senior Manager has end-to-end accountability for quality strategy and QA across Early Development through commercialization in Launch and Grow to Late Stage for biotherapeutics, leading cross-functional teams and ensuring regulatory readiness.

Qualifications

• Bachelor's degree in a technical/scientific field.
• 8+ years in the pharmaceutical/biotech industry with cGMP knowledge.
• Ability to influence and partner across organizations.

Responsibilities

• Represents Global Quality on CMC and Value Chain teams.
• Liaises between VCT and Analytical groups and serves as the Global Quality contact.
• Ensures quality stage-gate deliverables are achieved and filings are QA-reviewed.
• Defines QA resources and leads a product quality integration team from development to launch.
• Supports audits, regulatory filings, and cross-site quality governance.
• Drives risk assessment, CAPA, and continuous quality improvement.

Skills

Quality Management

Regulatory Compliance

GMP

Risk Assessment

Cross-functional Collaboration

SOP

CAPA

Quality Auditing

Education

Bachelor's degree in Pharmacy/Biology/Biochemistry/Biotechnology/Engineering

Job description

Johnson & Johnson Innovative Medicine (J&J IM) is recruiting a Senior Manager, Product Quality Integrator, Quality Asset Management Biotherapeutics. The position will be based at our European sites.

The Senior Manager has end-to-end accountability for quality strategy and QA across Early Development through commercialization in Launch and Grow to Late Stage for biotherapeutics, leading cross-functional teams and ensuring regulatory readiness.